# K190833: AXS Vecta Aspiration Catheter

- Pathway: 510(k) (Traditional)
- Applicant: Stryker Neurovascular
- Decided: Dec 15, 2019 after 258 days
- Product code: DQY (Catheter, Percutaneous)
- Device class: 2
- Regulation: 21 CFR 870.1250
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 8 generations back to K003880 (2001). 13 ancestors in all.
6 later devices descend from it; 2 cite it directly.
0 of 20 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K183463: AXS Catalyst Distal Access Catheter 068 x 115cm, AXS Catalyst Distal Access Catheter 068 x 125cm, AXS Catalyst Distal Access Catheter 068 x 132cm, Stryker (2019) Summary page 5.

## Most influential descendants
- K202752: AXS Vecta 46 Intermediate Catheter (2021), 3 descendants of its own
- K241244: CEREGLIDE 42 Intermediate Catheter; CEREGLIDE 57 Intermediate Catheter (2024), 1 descendant of its own
- K200206: AXS Vecta 71 Intermediate Catheter, AXS Vecta 74 Intermediate Catheter (2020), 1 descendant of its own
- K261176: Zoom 4S Catheter (2026), 0 descendants of its own
- K262398: CEREGLIDE 57 Intermediate Catheter; Cerenovus Aspiration Tubing set (2026), 0 descendants of its own

## Indications for use
The AXS Vecta Intermediate Catheter is indicated for use in facilitating the insertion and guidance of appropriately sized interventional devices into a selected blood vessel in the peripheral and neurovascular systems. The AXS Vecta Intermediate Catheter is also indicated for use as a conduit for retrieval devices.

Source page: https://510kreport.com/device/K190833
Methodology: https://510kreport.com/methodology